Pad Chivukula
Impact in
-
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- CRISPR and Genetic Engineering
-
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- RNA Interference and Gene Delivery 5
- Peroxisome Proliferator-Activated Receptors 2
-
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Kiyoshi Tachikawa (7 shared papers)Priya Karmali (5 shared papers)Jerel Vega (2 shared papers)Nina Tonnu (1 shared paper)Pattraranee Limphong (1 shared paper)Inder M. Verma (1 shared paper)Suvasini Ramaswamy (1 shared paper)Shu‐ichi Matsuzawa (2 shared papers)
- Journals
- Molecular Therapy — Nucleic Acids (3 papers)Molecular Therapy (1 paper)Scientific Reports (1 paper)Biomedicine & Pharmacotherapy (1 paper)npj Vaccines (1 paper)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Pad Chivukula
9 papers receiving 380 citations
Peers
Comparison fields: 5 of 59
- Molecular Biology 302
- Infectious Diseases 72
- Genetics 89
- Immunology 62
- Cancer Research 42
Countries citing papers authored by Pad Chivukula
This map shows the geographic impact of Pad Chivukula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pad Chivukula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pad Chivukula more than expected).
Fields of papers citing papers by Pad Chivukula
This network shows the impact of papers produced by Pad Chivukula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pad Chivukula. The network helps show where Pad Chivukula may publish in the future.
Co-authors
The 25 scholars most cited alongside Pad Chivukula, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 236 | |
| 2 | 2016 | 43 | |
| 3 | 2020 | 35 | |
| 4 | 2016 | 28 | |
| 5 | 2024 | 27 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 3 | |
| 10 | 2024 | 0 |
About Pad Chivukula
Pad Chivukula is a scholar working on Molecular Biology, Epidemiology, Infectious Diseases, Genetics and Surgery, having authored 10 papers that have together received 400 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Virus-based gene therapy research (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Hemophilia Treatment and Research (1 paper), MicroRNA in disease regulation (1 paper) and Cystic Fibrosis Research Advances (1 paper). The work is most often cited by research in Molecular Biology (302 citations), Infectious Diseases (72 citations), Genetics (89 citations), Immunology (62 citations) and Cancer Research (42 citations). Pad Chivukula has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Kiyoshi Tachikawa, Priya Karmali, Jerel Vega, Nina Tonnu, Pattraranee Limphong, Inder M. Verma, Suvasini Ramaswamy, Shu‐ichi Matsuzawa, Teruki Yanagi and Asami Hishiki. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Molecular Therapy, Scientific Reports, Biomedicine & Pharmacotherapy and npj Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.